P3 Health Partners Inc.(PIII)

Medical - Care Facilities · Henderson, NV

$6.00-0.17 (-2.84%)

Delayed quote: Oct 6, 2026, 12:29 PM EDT

EV/FCF Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/FCF ratio is N/A as of 2026-10-06T16:34:05.008Z.

Stored calculation inputs

Calculation as of: 2026-10-06T16:34:05.008Z.

Quote observation: 2026-10-06T16:29:47.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 19,639,626
Total debt · period ending 2026-06-30: 130,271,000
Cash · period ending 2026-06-30: 21,272,000
TTM free cash flow · period ending 2026-06-30: -130,520,000

FMP input reference: ac2c7a41ad5640622b079511a65f3d79aa9aa97fd30809e3a9f0c7038551df0a

Free Cash Flow|FCF Yield|P/FCF Ratio|EV/EBITDA|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

PIII EV/FCF Ratio Metrics

EV/FCF RATIO

N/A

PIII Competitors' EV/FCF Ratio

PIII

P3 Health Partners Inc.

Current

Market Cap

$19.64M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NXTC

NextCure, Inc.

vs PIII

Market Cap

$19.42M

EV/FCF Ratio

N/A

TTM Avg

232.26x

3Y Avg

232.26x

5Y Avg

232.26x

ACTU

Actuate Therapeutics Inc

vs PIII

Market Cap

$19.98M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NEUP

Neuphoria Therapeutics Inc.

vs PIII

Market Cap

$18.86M

EV/FCF Ratio

N/A

TTM Avg

281.92x

3Y Avg

1403.45x

5Y Avg

1403.45x

ESLA

Estrella Immunopharma, Inc.

vs PIII

Market Cap

$18.60M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

QNTM

Quantum BioPharma Ltd.

vs PIII

Market Cap

$20.80M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

COSM

Cosmos Health Inc.

vs PIII

Market Cap

$17.81M

EV/FCF Ratio

N/A

TTM Avg

14.44x

3Y Avg

40.11x

5Y Avg

40.11x

MODD

Modular Medical, Inc.

vs PIII

Market Cap

$21.76M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LPCN

Lipocine Inc.

vs PIII

Market Cap

$17.19M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PAVM

PAVmed Inc.

vs PIII

Market Cap

$17.17M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/FCF RATIO	TTM	3Y	5Y
P3 Health Partners Inc. (PIII)	$19.64M	N/A	N/A	N/A	N/A
NextCure, Inc. (NXTC)vs ›	$19.42M	N/A	232.26x	232.26x	232.26x
Actuate Therapeutics Inc (ACTU)vs ›	$19.98M	N/A	N/A	N/A	N/A
Neuphoria Therapeutics Inc. (NEUP)vs ›	$18.86M	N/A	281.92x	1403.45x	1403.45x
Estrella Immunopharma, Inc. (ESLA)vs ›	$18.60M	N/A	N/A	N/A	N/A
Quantum BioPharma Ltd. (QNTM)vs ›	$20.80M	N/A	N/A	N/A	N/A
Cosmos Health Inc. (COSM)vs ›	$17.81M	N/A	14.44x	40.11x	40.11x
Modular Medical, Inc. (MODD)vs ›	$21.76M	N/A	N/A	N/A	N/A
Lipocine Inc. (LPCN)vs ›	$17.19M	N/A	N/A	N/A	N/A
PAVmed Inc. (PAVM)vs ›	$17.17M	N/A	N/A	N/A	N/A

Cash Flow Valuation Comparison

EV/FCF

N/A

P/FCF

N/A

FCF Yield

N/A

Formula: EV/FCF = Enterprise Value / Free Cash Flow

EV/FCF vs P/FCF:

EV/FCF accounts for debt and cash through enterprise value
P/FCF only considers equity value
EV/FCF can be compared across companies with different debt levels
Both measure how the market values cash generation

EV/FCF Ratio Formula & Definition

EV/FCF = Enterprise Value / Free Cash Flow (TTM)

Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EV/FCF Ratio: N/A

PIII EV/FCF Ratio Metrics

PIII Competitors' EV/FCF Ratio

Cash Flow Valuation Comparison

EV/FCF Ratio Formula & Definition

Related Metrics